Haabeth O, Lorvik K, Hammarstrom C, Donaldson I, Haraldsen G, Bogen B
Nat Commun. 2011; 2:240.
PMID: 21407206
PMC: 3072106.
DOI: 10.1038/ncomms1239.
Kataoka T, Sakurai Y, IDA N
Cancer Chemother Pharmacol. 1982; 9(2):75-80.
PMID: 7172408
DOI: 10.1007/BF00265382.
Tsujimoto M, Tarutani T, Ogawa K, Akashi K, Okubo Y, Higashi N
Infect Immun. 1983; 41(1):181-4.
PMID: 6407996
PMC: 264760.
DOI: 10.1128/iai.41.1.181-184.1983.
Weigent D, Langford M, Fleischmann Jr W, STANTON G
Infect Immun. 1983; 40(1):35-8.
PMID: 6403469
PMC: 264814.
DOI: 10.1128/iai.40.1.35-38.1983.
Nagai M, Arai T
Neurosurg Rev. 1984; 7(1):55-64.
PMID: 6379511
DOI: 10.1007/BF01743290.
Induction of gamma-interferon activity by elevated temperatures in human B-lymphoblastoid cell lines.
Taylor M, Long T, Martinez-Valdez H, Downing J, Zeige G
Proc Natl Acad Sci U S A. 1984; 81(13):4033-6.
PMID: 6330733
PMC: 345362.
DOI: 10.1073/pnas.81.13.4033.
Interferon potentiation occurs at a pretranscriptive stage.
Schwarz L, Fleischmann Jr W
Infect Immun. 1983; 39(1):159-63.
PMID: 6185431
PMC: 347919.
DOI: 10.1128/iai.39.1.159-163.1983.
Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon.
Potter M, Moore M, Morris A
Immunology. 1982; 46(2):401-9.
PMID: 6177626
PMC: 1555369.
Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.
Devos R, Cheroutre H, Taya Y, Degrave W, Van Heuverswyn H, Fiers W
Nucleic Acids Res. 1982; 10(8):2487-501.
PMID: 6176945
PMC: 320629.
DOI: 10.1093/nar/10.8.2487.
Interferons as antitumor agents.
Kirchner H
J Cancer Res Clin Oncol. 1982; 103(1):1-6.
PMID: 6176585
DOI: 10.1007/BF00410300.
Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.
Pollard R
Drugs. 1982; 23(1-2):37-55.
PMID: 6173188
DOI: 10.2165/00003495-198223010-00002.
Stimulation of human gamma interferon production by diterpene esters.
Yip Y, Pang R, Oppenheim J, Nachbar M, Henriksen D, Vilcek J
Infect Immun. 1981; 34(1):131-9.
PMID: 6170583
PMC: 350832.
DOI: 10.1128/iai.34.1.131-139.1981.
Cloning and expression of the chromosomal immune interferon gene of the rat.
Dijkema R, van der Meide P, Pouwels P, Caspers M, Dubbeld M, Schellekens H
EMBO J. 1985; 4(3):761-7.
PMID: 3924594
PMC: 554253.
DOI: 10.1002/j.1460-2075.1985.tb03694.x.
Alpha interferon: a look to the future.
Bonnem E
Invest New Drugs. 1987; 5 Suppl:S65-75.
PMID: 3298135
DOI: 10.1007/BF00207265.
Superinduction of the human gene encoding immune interferon.
Lebendiker M, TAL C, Sayar D, Pilo S, Eilon A, Banai Y
EMBO J. 1987; 6(3):585-9.
PMID: 3107985
PMC: 553437.
DOI: 10.1002/j.1460-2075.1987.tb04794.x.
Enhanced production of gamma-interferon by therapy with parenteral OK-432 and alpha-interferon in patients with head and neck cancer.
Sugiyama M, Yamane H, Cho J, Okada H, Sugita M, Nakai Y
Arch Otorhinolaryngol. 1986; 243(5):281-7.
PMID: 3101655
DOI: 10.1007/BF00460202.
Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.
Khor M, Lowrie D, Coates A, Mitchison D
Br J Exp Pathol. 1986; 67(4):587-96.
PMID: 3091058
PMC: 2013056.
Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.
Dick R, Hubbell H
J Neurooncol. 1987; 5(4):331-8.
PMID: 2450181
DOI: 10.1007/BF00148390.
Antitumor effect of combination of murine recombinant interferon beta, murine recombinant interferon gamma and human recombinant interleukin-2 in MethA-bearing mice.
Itoh T, Sakata Y, Yoshida Y, Tsushima K, Suzuki H, Saitoh S
Cancer Immunol Immunother. 1990; 32(2):88-94.
PMID: 2126986
PMC: 11038152.
DOI: 10.1007/BF01754204.
Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma.
de Mulder P, Debruyne F, Franssen M, Geboers A, Strijk S, Reintjes A
Cancer Immunol Immunother. 1990; 31(5):321-4.
PMID: 2115817
PMC: 11038345.
DOI: 10.1007/BF01740941.
